In addition, the Secretary may conduct surveys, other data collection activities, studies, or other analyses, as the Secretary determines to be appropriate, to facilitate the review and appropriate adjustment of potentially misvalued services
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
doi:10.1007/s00125-009-1499-0
For most researchers, 4.0mL is the better choice
2014;S6:006
Step 3: Choose the Injection Site For intramuscular injection , common sites include: Deltoid muscle (upper arm) best for adults with adequate muscle mass Vastus lateralis (side of the thigh) ideal for self-injection Ventrogluteal or dorsogluteal (buttocks) often used in clinical settings Clean the site with an alcohol swab and allow it to dry
